PT2632550T - Métodos e composições para tratar diarreia associada a vih - Google Patents

Métodos e composições para tratar diarreia associada a vih

Info

Publication number
PT2632550T
PT2632550T PT118372499T PT11837249T PT2632550T PT 2632550 T PT2632550 T PT 2632550T PT 118372499 T PT118372499 T PT 118372499T PT 11837249 T PT11837249 T PT 11837249T PT 2632550 T PT2632550 T PT 2632550T
Authority
PT
Portugal
Prior art keywords
compositions
methods
treating hiv
associated diarrhea
hiv associated
Prior art date
Application number
PT118372499T
Other languages
English (en)
Portuguese (pt)
Inventor
Forbes William
Bortey Enoch
King Steven
Chaturvedi Pravin
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2632550(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of PT2632550T publication Critical patent/PT2632550T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT118372499T 2010-10-31 2011-10-31 Métodos e composições para tratar diarreia associada a vih PT2632550T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
PT2632550T true PT2632550T (pt) 2017-08-02

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PT118372499T PT2632550T (pt) 2010-10-31 2011-10-31 Métodos e composições para tratar diarreia associada a vih

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC10.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC10.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC10.html)
CN (2) CN103370101A (cg-RX-API-DMAC10.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC10.html)
CA (1) CA2816416C (cg-RX-API-DMAC10.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC10.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC10.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC10.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC10.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC10.html)
MX (1) MX348184B (cg-RX-API-DMAC10.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC10.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC10.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC10.html)
PT (1) PT2632550T (cg-RX-API-DMAC10.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC10.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
JP2016505561A (ja) * 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
AU2018275685B2 (en) 2017-05-31 2025-04-17 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
JP2020525407A (ja) 2017-05-31 2020-08-27 ナポ ファーマシューティカルズ インク.Napo Pharmaceuticals,Inc. 先天性下痢障害を治療するための方法及び組成物
JP2022523564A (ja) 2019-03-04 2022-04-25 アイオーカレンツ, インコーポレイテッド 機械学習を使用するデータ圧縮および通信
MX2022016367A (es) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
JP4195728B2 (ja) 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1937655A1 (en) * 2005-06-22 2008-07-02 University of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
NZ572049A (en) * 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
MX2014007635A (es) 2011-12-22 2014-09-22 Glenmark Pharmaceuticals Ltd Composicion farmaceutica no enterica que comprende crofelemer.
JP2016505561A (ja) 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物

Also Published As

Publication number Publication date
ZA201303136B (en) 2016-01-27
CN103370101A (zh) 2013-10-23
JP6063385B2 (ja) 2017-01-18
ES2635435T3 (es) 2017-10-03
HK1249036A1 (zh) 2018-10-26
PL2632550T3 (pl) 2017-10-31
EP2632550A4 (en) 2014-04-23
EP2632550A1 (en) 2013-09-04
AU2011320155A1 (en) 2013-05-09
US9585868B2 (en) 2017-03-07
US8962680B2 (en) 2015-02-24
MX348184B (es) 2017-06-02
ECSP13012650A (es) 2013-10-31
US20120107370A1 (en) 2012-05-03
PH12013500857A1 (en) 2018-01-17
BR112013010774A2 (pt) 2017-03-21
EP2632550B1 (en) 2017-05-03
US20120184605A1 (en) 2012-07-19
WO2012058664A1 (en) 2012-05-03
CA2816416C (en) 2020-02-11
PE20140036A1 (es) 2014-01-31
AU2011320155B2 (en) 2016-02-25
CN107595836A (zh) 2018-01-19
US20150190367A1 (en) 2015-07-09
RU2597746C2 (ru) 2016-09-20
JP6310971B2 (ja) 2018-04-11
RU2013123794A (ru) 2014-12-10
JP2017019806A (ja) 2017-01-26
HUE035393T2 (en) 2018-05-02
US20140294903A1 (en) 2014-10-02
CA2816416A1 (en) 2012-05-03
DK2632550T3 (en) 2017-08-07
JP2013540826A (ja) 2013-11-07
MX2013004873A (es) 2013-08-21

Similar Documents

Publication Publication Date Title
PT2890780T (pt) Métodos e composições para tratamento de uma condição genética
BR112012024303A2 (pt) composição modificada para impacto e artigo fabricado
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
EP2758441A4 (en) MODIFIED POLYETHYLENE COMPOSITIONS
LT2791160T (lt) Modifikuotos mrnr sudėtys
PT2755675T (pt) Composições de péptido semelhante a glucagão-2 e métodos para produzir e utilizar as mesmas
CO6990720A2 (es) Composiciones que comprenden galatos y galamidas
BR112013015452A2 (pt) composições e métodos para modular fxr
LT3702351T (lt) Kompozicijos, apimančios mek inhibitorių
PT3278800T (pt) Composições e métodos para melhorar a função mitocondrial e tratar condições patológicas relacionadas com músculos
PL2976946T3 (pl) Kompozycje cyklodekstryny, wyroby i sposoby
CL2013000460A1 (es) Polipeptidos que enlazan miostatina, composiciones y metodos
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
PT2718434T (pt) Composições e métodos para tratar a doença de espru celíaco
PL2632550T3 (pl) Sposoby i kompozycja do leczenia biegunki związanej z HIV
BRPI1013927A2 (pt) métodos e composições para o tratamento de lúpus
IL232648A0 (en) Preparations and methods for treating glioma
EP2755486A4 (en) DISINFECTING COMPOSITIONS AND USES THEREOF
EP2785176A4 (en) ANTIMICROBIAL COMPOSITIONS AND CORRESPONDING METHODS
EP2722366A4 (en) CURABLE COMPOSITION
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
EP2879670A4 (en) ANTIBACTERIAL COMPOSITIONS AND METHOD
BR112014010769A2 (pt) métodos e composições para neuroproteção
BR112014001249A2 (pt) composições de amaciante e desaglutinação
EP2668044A4 (en) COMPOSITIONS AND THEIR USE